An investigational oral selective orexin receptor 2 agonist significantly improved measures of wakefulness, sleepiness, and ...

Frustrated by long wait times and high costs, some are turning away from traditional, insurance-based health care in search ...

Frustrated by long wait times and high costs, some are turning away from traditional, insurance-based health care in search ...

Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ETCompany ParticipantsKatie Falzone - Senior Vice President, ...

Takeda (TSE: 4502/NYSE:TAK ) today announced that the New England Journal of Medicine published data from the Phase 2b ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 5 undervalued ...

Another $5 billion will go into the province’s infrastructure bank, the Building Ontario Fund, which was announced in the ...

A University of Alberta-led study has put to rest a long-standing controversy about the best time of day to take blood ...

A baby born with a rare and dangerous genetic disease is thriving after getting an experimental gene editing treatment made ...

Lawmakers introduced a measure proposing a higher dispensary purchasing limit, bills addressing the state's declining pot tax ...

A major driver of Arialief's popularity is the "7-second nerve relief trick” video that has been shared thousands of times.

AML patients achieve remission with mipletamig + standard of care across two trialsMipletamig triplet combination continues to outperform standard doublet benchmarkNo cytokine release ...